Thomas B. Knudsen

Dr. Thomas B. Knudsen

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2013 in Chemical Research in Toxicology
Verified
Journal Article
Open access
NSNisha S. Sipes
Nisha S. Sipes
MMMatthew T. Martin
Matthew T. Martin
PKParth Kothiya
Parth Kothiya
David ReifDavid Reif
David Reif
RJRichard Judson
Richard Judson
TKThomas B. Knudsen
Thomas B. Knudsen
Understanding potential health risks is a significant challenge due to the large numbers of diverse chemicals with poorly characterized exposures and mechanisms of toxicities. The present study analyzes 976 chemicals (including failed pharmaceuticals, alternative plasticizers, food additives, and pesticides) in Phases I and II of the U.S. EPA’s ToxCast project across 331 cell-free enzymatic and ligand-binding high-throughput screening (HTS) assays. Half-maximal activity concentrations (AC50) were identified for 729 chemicals in 256 assays (7,135 chemical–assay pairs). Some of the most commonly affected assays were CYPs (CYP2C9 and CYP2C19), transporters (mitochondrial TSPO, norepinephrine, and dopaminergic), and GPCRs (aminergic). Heavy metals, surfactants, and dithiocarbamate fungicides showed promiscuous but distinctly different patterns of activity, whereas many of the pharmaceutical compounds showed promiscuous activity across GPCRs. Literature analysis confirmed >50% of the activities for the most potent chemical–assay pairs (54) but also revealed 10 missed interactions. Twenty-two chemicals with known estrogenic activity were correctly identified for the majority (77%), missing only the weaker interactions. In many cases, novel findings for previously unreported chemical–target combinations clustered with known chemical–target interactions. Results from this large inventory of chemical–biological interactions can inform read-across methods as well as link potential targets to molecular initiating events in adverse outcome pathways for diverse toxicities.

1 March 2011 in Toxicology
Verified
Journal Article
Closed access
TKThomas B. Knudsen
Thomas B. Knudsen
KHKeith A. Houck
Keith A. Houck
NSNisha S. Sipes
Nisha S. Sipes
ASAmar V. Singh
Amar V. Singh
RJRichard Judson
Richard Judson
RKRobert J. Kavlock
Robert J. Kavlock

1 September 2009 in Reproductive Toxicology
Verified
Journal Article
Closed access
TKThomas B. Knudsen
Thomas B. Knudsen
MMMatthew T. Martin
Matthew T. Martin
RKRobert J. Kavlock
Robert J. Kavlock
RJRichard Judson
Richard Judson
DDDavid J. Dix
David J. Dix
ASAmar V. Singh
Amar V. Singh

4 April 2013 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
NKNicole Kleinstreuer
Nicole Kleinstreuer
DDDavid Dix
David Dix
MRMichael Rountree
Michael Rountree
NBNancy Baker
Nancy Baker
NSNisha Sipes
Nisha Sipes
TKThomas B. Knudsen
Thomas B. Knudsen
Vascular development is a complex process regulated by dynamic biological networks that vary in topology and state across different tissues and developmental stages. Signals regulating de novo blood vessel formation (vasculogenesis) and remodeling (angiogenesis) come from a variety of biological pathways linked to endothelial cell (EC) behavior, extracellular matrix (ECM) remodeling and the local generation of chemokines and growth factors. Simulating these interactions at a systems level requires sufficient biological detail about the relevant molecular pathways and associated cellular behaviors, and tractable computational models that offset mathematical and biological complexity. Here, we describe a novel multicellular agent-based model of vasculogenesis using the CompuCell3D (http://www.compucell3d.org/) modeling environment supplemented with semi-automatic knowledgebase creation. The model incorporates vascular endothelial growth factor signals, pro- and anti-angiogenic inflammatory chemokine signals, and the plasminogen activating system of enzymes and proteases linked to ECM interactions, to simulate nascent EC organization, growth and remodeling. The model was shown to recapitulate stereotypical capillary plexus formation and structural emergence of non-coded cellular behaviors, such as a heterologous bridging phenomenon linking endothelial tip cells together during formation of polygonal endothelial cords. Molecular targets in the computational model were mapped to signatures of vascular disruption derived from in vitro chemical profiling using the EPA's ToxCast high-throughput screening (HTS) dataset. Simulating the HTS data with the cell-agent based model of vascular development predicted adverse effects of a reference anti-angiogenic thalidomide analog, 5HPP-33, on in vitro angiogenesis with respect to both concentration-response and morphological consequences. These findings support the utility of cell agent-based models for simulating a morphogenetic series of events and for the first time demonstrate the applicability of these models for predictive toxicology. We built a novel computational model of vascular development that includes multiple cell types responding to growth factor signaling, inflammatory chemokine pathways and extracellular matrix interactions. This model represents the normal biology of capillary plexus formation, both in terms of morphology and emergent behaviors. Based on in vitro high-throughput screening data from EPA's ToxCast program, we can simulate chemical exposures that disrupt blood vessel formation. Simulated results of an anti-angiogenic thalidomide compound were highly comparable to results in an endothelial tube formation assay. This model demonstrates the utility of computational approaches for simulating developmental biology and predicting chemical toxicity.

18 December 2017 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
KSKaterine S. Saili
Katerine S. Saili
TZTodd J. Zurlinden
Todd J. Zurlinden
ASAndrew J. Schwab
Andrew J. Schwab
ASAymeric Silvin
Aymeric Silvin
NBNancy C. Baker
Nancy C. Baker
TKThomas B. Knudsen
Thomas B. Knudsen

1 December 2011 in Birth Defects Research Part C: Embryo Today: Reviews
Verified
Journal Article
Closed access
PDF file
TKThomas B. Knudsen
Thomas B. Knudsen
NKNicole Kleinstreuer
Nicole Kleinstreuer